1. Journal searcher
  2. Top 15 journals in Pharmacology
  3. Chinese Journal of Cancer Biotherapy
Default: Chinese Journal of Cancer Biotherapy

ISSN: 1007-385X

Journal Home

Journal Guideline

Chinese Journal of Cancer Biotherapy Q4 Unclaimed

China
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Chinese Journal of Cancer Biotherapy is a journal indexed in SJR in Pharmacology and Molecular Medicine with an H index of 5. It has an SJR impact factor of 0,106 and it has a best quartile of Q4. It has an SJR impact factor of 0,106.

Type: Journal

Type of Copyright:

Languages:

Open Access Policy:

Type of publications:

Publication frecuency: -

DOAJ WOS
Categories: Cancer Research (Q4) Molecular Medicine (Q4) Pharmacology (Q4)
Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

Chinese Journal of Cancer Biotherapy

0,106

SJR Impact factor

5

H Index

0

Total Docs (Last Year)

332

Total Docs (3 years)

0

Total Refs

27

Total Cites (3 years)

332

Citable Docs (3 years)

0.1

Cites/Doc (2 years)

0.0

Ref/Doc

Comments

No comments ... Be the first to comment!
User post comment
* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Bangladesh Journal of Pharmacology Q4
European Journal of Oncology Pharmacy Q4
Pharmaceutical Chemistry Journal Q4
Prescrire International Q4
Biomedical and Pharmacology Journal Q4
Compare this journals

Aims and Scope

FAQS

What is the impact factor of Chinese Journal of Cancer Biotherapy?

In Country of Paypers you can find Impact factor and other metrics to help you decide on a Journal.